Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Mika, Miura"'
Autor:
Kozue Yamauchi, Mitsuaki Sato, Leona Osawa, Shuya Matsuda, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Ryo Katoh, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Mika Miura, Shinichi Takano, Fumitake Amemiya, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1634-1651 (2022)
Abstract The method of analyzing individual resistant hepatitis C virus (HCV) by a combination of haplotyping and resistance‐associated substitution (RAS) has not been fully elucidated because conventional sequencing has only yielded short and frag
Externí odkaz:
https://doaj.org/article/ed2bb1ef2ec34944a32c1774f94c9bc1
Autor:
Akihisa Tatsumi, Shinya Maekawa, Leona Osawa, Ryo Katoh, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Ei Takahashi, Mika Miura, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Yasuhiro Nakayama, Taisuke Inoue, Hiroki Okada, Takuji Araki, Hiroshi Onishi, Nobuyuki Enomoto
Publikováno v:
JGH Open, Vol 6, Iss 2, Pp 139-147 (2022)
Abstract Background and Aim Recently, balloon‐occluded retrograde transvenous obliteration (BRTO), performed for spontaneous portosystemic shunts (SPSS), has been receiving attention as a measure to improve liver function in cirrhotic patients with
Externí odkaz:
https://doaj.org/article/70ae4df429b84522b3e0823ff7465372
Autor:
Masaru Muraoka, Shinya Maekawa, Ryo Katoh, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Yuichiro Suzuki, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Fumitake Amemiya, Hiroko Shindo, Shinichi Takano, Mitsuharu Fukasawa, Kozue Yamauchi, Tatsuya Yamaguchi, Yasuhiro Nakayama, Taisuke Inoue, Nobuyuki Enomoto
Publikováno v:
Hepatology Communications, Vol 5, Iss 11, Pp 1927-1938 (2021)
Although the usefulness of liquid biopsy as a biomarker in the treatment of hepatocellular carcinoma (HCC) has been suggested, its usefulness in transcatheter arterial chemoembolization (TACE) or tyrosine kinase inhibitor (TKI) therapies has not been
Externí odkaz:
https://doaj.org/article/93723454b91843beafbc574adb0a7ec6
Autor:
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212559 (2019)
AimDeletions are observed frequently in the preS1/S2 region of hepatitis B virus (HBV) genome, in association with liver disease advancement. However, the most significant preS1/S2 region and its influences on viral markers are unclear.MethodsThe pre
Externí odkaz:
https://doaj.org/article/ac07c23d116a47d083bcfc91d7051d24
Autor:
TAKANOBU HOSHI, KEI WATANABE, YUTA FUKUMURA, KOJI MIYAZAKI, MADOKA TAKAHASHI, SAKAE TANIGUCHI, NAOKI WADA, MIKA MIURA, SHOYA KATO, KAZUNORI YAMADA, SATOSHI FUJII, HIDEKI SATO
Publikováno v:
In Vivo; Sep/Oct2023, Vol. 37 Issue 5, p2197-2202, 6p
Autor:
Tatsuya Yamaguchi, Nobuyuki Enomoto, Yuichiro Suzuki, Atsuya Yamashita, Mika Miura, Shinichi Takano, Natsuko Nakakuki, Shinya Maekawa, Yasuyuki Komiyama, Tadashi Sato, Taisuke Inoue, Kohji Moriishi, Mitsuharu Fukasawa, Fumitake Amemiya, Hiroko Shindo, Shuya Matsuda, Akihisa Tatsumi, Mitsuaki Sato, Yasuhiro Nakayama, Masaru Muraoka
Publikováno v:
Hepatology Research. 51:39-50
AIM Recently, serum hepatitis B virus (HBV)-RNA has been reported to be detectable even when HBV particle production is inhibited by nucleot(s)ide analogues (NAs). However, the dynamics of the HBV-RNA sequence compared with those of HBV-DNA during th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abfe210502300ecf3fcf2b56b1d69bf
https://doi.org/10.1111/hepr.13574
https://doi.org/10.1111/hepr.13574
Autor:
Kuniaki Shindo, Shinya Maekawa, Nobutoshi Komatsu, Akihisa Tatsumi, Mika Miura, Mitsuaki Sato, Yuichiro Suzuki, Shuya Matsuda, Masaru Muraoka, Fumitake Amemiya, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Yasuhiro Nakayama, Tomoyoshi Uetake, Taisuke Inoue, Minoru Sakamoto, Tadashi Sato, Nobuyuki Enomoto
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Since it remains elusive whether and how the imaging surveillance affects the survival in patients with non-B, non-C hepatocellular carcinoma (NBNC-HCC), we conducted this retrospective study which investigated the association between the semiannual
Externí odkaz:
https://doaj.org/article/cbf1ad9e7bd6411d8d12a309ddd9e8ac
Autor:
Shinichi Takano, Mitsuharu Fukasawa, Shinya Maekawa, Makoto Kadokura, Mika Miura, Hiroko Shindo, Ei Takahashi, Tadashi Sato, Nobuyuki Enomoto
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98718 (2014)
To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related gene profiling analyses using pure pancreatic juice and resected pancreatic tissues.Pure
Externí odkaz:
https://doaj.org/article/577f1a973b4743a291dd6d2ec5967b2c
Autor:
Atsuko Kitahashi, Ikko Watanabe, Masahiko Ohtaka, Yuichi Hirose, Kazuhiko Takaso, Mika Miura, Mitsuhiko Hanawa, Naoki Imamura, Nobuyuki Enomoto, Yoshioki Yoda, Naoki Shimura, Mitsuharu Fukasawa, Ichiro Takayama
Publikováno v:
Open Journal of Gastroenterology. :27-38
Aim: To investigate the efficacy and tolerability of second-line metronidazole triple therapy with vonoprazan (VPZ) for Helicobacter pylori (H. pylori). Methods: We retrospectively reviewed medical records of patients who experienced clarithromycin t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a179644d8e439fa06db6833040a7c4c
https://doi.org/10.4236/ojgas.2018.81003
https://doi.org/10.4236/ojgas.2018.81003
Autor:
Makoto Kadokura, Shinya Maekawa, Ryota Sueki, Mika Miura, Kazuki Komase, Hiroko Shindo, Fumitake Amemiya, Tomoyoshi Uetake, Taisuke Inoue, Minoru Sakamoto, Mina Nakagawa, Naoya Sakamoto, Mamoru Watanabe, Nobuyuki Enomoto
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24514 (2011)
BACKGROUND AND AIMS: Patients infected with genotype 2b hepatitis C virus (HCV) generally can achieve favorable responses to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV). However, a proportion of patients show poorer responses and the co
Externí odkaz:
https://doaj.org/article/fc0bfe67e3e1452e81ee97182e561ff6